Small Molecule Inhibitor of ITK Disrupts TCR Signaling and Demonstrates Anti-Tumor Efficacy

被引：0

作者：

Faris, Mary ^{[1
]}

Malyankar, Uriel M. ^{[1
]}

Zeng, Qingping ^{[1
]}

Flynn, Gary A. ^{[2
]}

Fuer, Gerold ^{[3
]}

Kertesz, Nathalie L. ^{[1
]}

Vuga, Danka ^{[1
]}

Lee, Sandra ^{[4
]}

Rosario, Darlene ^{[1
]}

Bot, Adrian ^{[1
]}

机构：

[1] MannKind Corp, Valencia, CA USA

[2] Spacefill Enterprises LLC, Oro Valley, AZ USA

[3] SUNY Upstate Med Univ, Syracuse, NY USA

[4] Biogen Idec Inc, San Diego, CA USA

来源：

BLOOD | 2010年 / 116卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1603 / 1604

页数：2

共 50 条

[21] Inhibition of Weel kinase by small molecule inhibitor enhances anti-tumor efficacy of DNA damaging agents specifically in p53-negative cancers
Hirai, Hiroshi
Iwasawa, Yoshikazu
Okada, Megumu
Arai, Tsuyoshi
Nishibata, Toshihide
Kobayashi, Makiko
Kimura, Toshifumi
Kaneko, Naoki
Ohtani, Junko
Sakai, Takumi
Mizuarai, Shinji
Yoshizumi, Takashi
Kotani, Hidehito
CANCER RESEARCH, 2009, 69
[22] Rogaratinib, a small molecule pan-FGFR inhibitor potently inhibits FGFR4-phosphorylation and exerts anti-tumor efficacy in vivo and in vitro
Politz, Oliver
Gruenewald, Sylvia
Walter, Alexander
Siegel, Franziska
Scholz, Arne
Bender, Sebastian
Kneip, Christoph
Ellinghaus, Peter
CANCER RESEARCH, 2018, 78 (13)
[23] Effects of antibiotics on the anti-tumor efficacy of immune checkpoint inhibitor therapy
Nie, Fangfang
Guo, Jungang
Pan, Jiayi
Guo, Zhaojiao
Wang, Chun
Yan, Jun
Ma, Weina
CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (02): : 790 - 799
[24] MLN8054, an Aurora A Kinase inhibitor, demonstrates potent anti-tumor activity in disseminated tumor models
Zhang, M.
Meetze, M.
Huck, J.
Silva, M.
Sells, T.
Claiborne, C.
Manfredi, M.
EJC SUPPLEMENTS, 2006, 4 (12): : 113 - 113
[25] An oral and selective CDK12 inhibitor demonstrates robust anti-tumor activity.
Hu, Shanhu
Moebius, David
Dworakowski, Wojciech
Cooper, Elliott
LaPlaca, Derek
Alnemy, Sydney
Perera, Phone
Marineau, Jason
Chuaqui, Claudio
Carulli, John P.
Olson, Eric
CANCER RESEARCH, 2022, 82 (12)
[26] Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma
Gabata, Ryosuke
Harada, Kenichi
Mizutani, Yuki
Ouchi, Hirofumi
Yoshimura, Kaori
Sato, Yasunori
Kitao, Azusa
Kimura, Kiminori
Kouji, Hiroyuki
Miyashita, Tomoharu
Tajima, Hidehiro
Ohta, Tetsuo
ANTICANCER RESEARCH, 2020, 40 (09) : 5211 - 5219
[27] CB-708, an orally bioavailable small molecule inhibitor of CD73 with immunostimulatory and anti-tumor activity
Lee, Clarissa
Bhupathi, Deepthi
Billedeau, Roland
Chen, Jason
Chen, Lijing
Dang, Rosalyn
Gross, Matthew
Huang, Tony
Li, Weiqun
Ma, Yong
MacKinnon, Andrew
Marguier, Gisele
Neou, Silinda
Parlati, Francesco
Sotirovska, Natalija
Spurlock, Sandra
Stanton, Timothy
Steggerda, Susanne
Zhang, Jing
Zhang, Winter
Li, Jim
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[28] NOVEL SMALL MOLECULE HPK1 INHIBITOR PCC-1 INDUCES STRONG ANTI-TUMOR ACTIVITY
Das, Sanjib
Mandadi, Sravan
Saini, Jagmohan
Chaudhari, Sachin
Deshpande, Ameya
Chinnapattu, Murugan
Bajpai, Malini
Pangre, Priyanka
Potdar, Varada
Marathe, Megha
Sawant, Pooja
Akarte, Atul
Misra, Chandrasekhar
Das, Subhadip
Singh, Anuj
Das, Avratanu
Lambade, Pandurang
Tirumalasetty, Chaitanya
Patole, Raju
Biswas, Nilanjana
Karande, Vikas
Shah, Heta
Behera, Dayanidhi
Gowda, Nagaraj
Iyer, Pravin
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A889 - A889
[29] Active Immunotherapy With Prostvac® Demonstrates Potent Anti-tumor Efficacy in a Mouse Model of Prostate Cancer
Rountree, Ryan B.
Mandl, Stefanie J.
Cote, Joseph
dela Cruz, Tracy
Giffon, Thierry
Gordon, Evan
Foy, Susan P.
Lombardo, John R.
Trent, Erica
Laus, Reiner
Delcayre, Alain
JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 772 - 773
[30] Engineering armored TCR-modified T cells to enhance anti-tumor efficacy.
Drakes, Dylan J.
Rafiq, Sarwish
Purdon, Terence
Brentjens, Renier
CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 56 - 57

← 1 2 3 4 5 →